CLINICAL_TRIALS
trial_result
· 2014-12-10
Clinical Trial Update: Effects of LY2189265 on Glycemic Control in Participants With Type 2 Diabetes [Phase 2]
Summary
A Phase 2 clinical trial evaluating LY2189265 for glycemic control in adults with Type 2 diabetes has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2014-12-10